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Background   Multiple epiphyseal dysplasia (MED) is a common 
genetically and clinically heterogeneous skeletal dysplasia charac-
terized by early-onset osteoarthritis, mainly in the hip and knee, 
and mild-to-moderate short stature. Here we report on a 6-gen-
eration MED family with 17 affected members.
Method   The clinical and radiographic data on the 12 affected 
members still living were scrutinized. A structured inquiry com-
prising state of health and MED-related symptoms since birth up 
to the present time and the osteoarthritis outcome (KOOS) ques-
tionnaire were sent to all living family members with MED. The 
5 known gene loci for autosomal dominant MED were analyzed 
for  linkage,  using  fluorescence-labeled  microsatellite  markers. 
Linkage was ascertained with markers close to the COL9A2 gene, 
which was analyzed for mutations by sequencing.
Results   We identified an exon 3 donor splice mutation in the 
COL9A2  gene  in  all  affected  family  members.  Clinical,  radio-
graphic, and questionnaire data from affected family members 
suggested that MED caused by COL9A2 mutations starts in early 
childhood with knee pain accompanied by delayed ossification 
of femoral epiphyses. The disease then either stabilizes during 
puberty or progresses with additional joints becoming affected; 
joint surgery might be necessary. The progression of the disease 
also affects muscles, with increasing atrophy, resulting in muscle 
fatigue and pain. Muscular atrophy has not been reported earlier 
in cases with COL9A2 mutations.
Interpretation   In a patient with clinically suspected or verified 
MED, it is important to perform DNA-based analysis to identify 
a possible disease-causing mutation. This information can be used 
to carry out genetic risk assessment of other family members and 
to achieve an early and correct diagnosis in the children. 

 
Multiple epiphyseal dysplasia (MED) is an autosomal domi-
nant skeletal dysplasia that affects approximately 1 in 10,000 
individuals. It was first described in 1937, by the Swedish 
radiologist Ribbing. The predominant features of the disease 
are delayed and irregular ossification of epiphyses and early 
onset of osteoarthritis. The MED symptoms appear during 
early childhood, usually with pain in the knees after exercise. 
Children who are affected often have difficulty in getting up 
from the floor and have a waddling gait. They frequently com-
plain of fatigue during long walking. Adult height is usually 
in the lower range of normal. The limbs are relatively short in 
comparison to the trunk. Pain and joint deformities progress 
with age, resulting in early-onset osteoarthritis, particularly of 
the large weight-bearing joints. The spine is usually normal 
(Briggs and Chapman 2002, Jakkula et al. 2005, Zanki et al. 
2007). The diagnosis of the dominant form of MED is based 
on physical examination and radiographic findings in the pro-
band and other family members (Lachman et al. 2005). 
In many cases, the disease-causing gene mutation is known; 
mutations in 5 different genes have been identified to cause 
dominant MED. These genes are COMP, which encodes car-
tilage  oligomeric  matrix  protein;  COL9A1,  COL9A2,  and 
COL9A3, which code for the 3 alpha chains of cartilage-spe-
cific type IX collagen; and MATN3, which encodes matrilin-3, 
a cartilage extracellular matrix protein. COMP is mutated in 
80% of all MED samples analyzed. In approximately 10–20% 
of all samples tested, a mutation cannot be identified in any 
of the 5 known genes mentioned above, suggesting that muta-
tions in other hitherto unidentified genes are also involved in 
the  pathogenesis  of  dominant  MED  (Briggs  and  Chapman 
2002, Zanki et al. 2007). There is also a rare autosomal reces-
sive form of MED that is caused by mutations in a sulfate 
transporter gene (DTDST). This form of MED is characterized 
by malformations of the hands, feet, and knees, with a double-
layered patella and scoliosis (Ballhausen et al. 2003).
We  present  a  clinical  and  genetic  study  of  a  6-genera-
tion family with autosomal dominant MED. The individuals 
affected were of different ages and some of them had had 
MED symptoms for almost 90 years. The aim of the study was 712  Acta Orthopaedica 2009; 80 (6): 711–715
to investigate the symptoms of the affected family members, 
to analyze the development of the disease over time, and to 
identify the mutation that causes the disease in this family.
Material and methods
Family material and clinical investigations
In the present 6-generation MED family, 17 members were or 
had been affected (Figure 1). The hospital records with clini-
cal and radiographic data concerning the 12 affected members 
who were still living were scrutinized. 12 cases in 3 generations 
of the family have been examined earlier clinically and radio-
graphically (Ödman 1959). A structured inquiry covering the 
state of health and MED-related symptoms from birth up to 
the present time and also the Swedish version of knee injury 
and osteoarthritis outcome (KOOS) questionnaire (Roos et al. 
2003) were sent to all living family members with MED.
Genotyping of candidate genes and mutation analysis
Blood samples were collected from 24 family members (12 
affected, 9 healthy, and 3 whose disease state was unknown) 
after obtaining informed consent. Genomic DNA was extracted 
from  peripheral  lymphocytes  according  to  standard  proce-
dures. The  5  known  gene  loci  (COMP,  MATN3,  COL9A1, 
COL9A2,  COL9A3)  for  autosomal  dominant  MED  were 
genotyped using fluorescence-labeled microsatellite markers 
and 25 ng of DNA per PCR reaction, as described previously 
(Klar et al. 2004). Genotypes were analyzed with PeakScan-
ner v.1.0 (Applied Biosystems), haplotypes were drawn with 
Cyrillic v.2.1.3, and 2-point logarithms of odds (LOD) scores 
were calculated using MLINK (from the LINKAGE package 
v.5.1) (Lathrop and Laouel 1984). The COL9A2 gene was 
analyzed for mutations by DNA sequencing of exon 3 and 
intron 3, using the BigDye Terminator v3.1 Cycle Sequenc-
ing Kit (Invitrogen) and an ABI PRISM 3730 DNA analyser 
(Applied  Biosystems). The  DNA  sequences  obtained  were 
analyzed with Sequencher v.4.1.2 (Gene Codes Corporation, 
Ann Arbor, MI).
Results
Clinical findings
The presenting symptoms of the 12 living family members 
with MED were pain in the knees and fatigue during long 
walks at 2–7 years of age (Table). The main radiographic find-
ings were delayed ossification of the epiphyses of the hips and 
knees, irregular bone structures, and irregular jagged contours 
of the distal femoral epiphyses (Figure 2). Most of the indi-
viduals  affected  had  relatively  mild  manifestations  during 
early adulthood (Figure 3), but at 35–40 years of age many 
suffered from increasing pain in the knees and hips, resulting 
in functional disability. Restricted movements of the elbows 
and  knees  were  common.  Degenerative  osteoarthritis  and 
sometimes osteochondritis dissecans (Figure 4) was seen on 
radiographs. A few cases had undergone surgical removal of 
loose cartilaginous fragments from the knees. In a few cases, 
total hip replacement was required. After the age of 40 many 
had developed a scoliosis. All the affected family members 
had had slim muscles since birth, and after the age of 35–40 
slight-to-moderate muscular atrophy was common. In one of 
the patients, severe muscular atrophy after the age of 80 was 
seen. The adult heights of the MED patients were in the lower 
normal  range or  slightly shorter.  The  hands  and  feet  were 
small.
The disorder varied strikingly within the family. For exam-
ple, a 95-year-old male patient (III:2) had a relatively mild 
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Figure 1. Pedigree of the 6-generation family showing the 17 members affected by multiple epiphyseal dyspla-
sia. Black symbols represent affected individuals. An arrow indicates the proband.Acta Orthopaedica 2009; 80 (6): 711–715  713
form of the disease with only slight pain in the knees during 
early childhood. He was then free of symptoms until the age 
of 27, after which he had a few episodes of pain in the knees 
caused by osteochondritis dissecans. No surgery was needed. 
By the age of 60 he suffered from slight pain in the hips, and 
this pain began to increase at the age of 88, requiring bilateral 
hip replacement when he was 93. In contrast, a 93-year-old 
female patient (III:6) had a severe form of MED. From the 
age of 4, she had pain in the knees when weight bearing and 
difficulty in walking. At the age of 14 she began to suffer from 
dull ache in the knees. Knee surgery with removal of loose 
cartilaginous fragments was performed when she was 19 years 
old, and again at the age of 85. After the age of 35 she had 
increasing, disabling pain in several joints and in muscles. She 
had total hip replacements at the age of 65 and at 76. At the 
age of 85 severe muscular atrophy developed, with motor dis-
ability, and she became confined to a wheelchair. 
The 8 females affected had a more severe form of MED than 
the 4 males, and together they had undergone 11 orthopedic 
operations. Only 1 of the 4 males needed orthopedic surgery. 
All the adult family members affected had a university educa-
tion and full-time employment.
Linkage and mutation analysis
Haplotype construction and linkage analysis of the 5 gene loci 
for autosomal dominant MED was performed with DNA from 
the 24 family members. Linkage was excluded for the COMP, 
MATN3, COL9A1, and COL9A3 loci. A positive linkage to 
the disease was obtained with marker D1S1598 close to the 
COL9A2 gene (maximum LOD score of 2.7). The COL9A2 
gene was analyzed for mutations by sequencing of exon 3 and 
intron 3—the part of the gene where mutations have been iden-
tified in previous MED patients (Muragaki et al. 1996, Holden 
et al. 1999, Fiedler et al. 2002). A single nucleotide alteration, 
a T to C transition (IVS3DS [+2] T>C), was identified in the 
exon 3/intron 3 donor splice site in a heterozygous state in 
all 12 affected individuals from whom DNA was available. 
Analysis of the 9 healthy family members and of 3 individuals 
whose disease state was unknown confirmed that they did not 
carry the mutation.
Clinical findings in the MED patients
Patient   Present  Sex   Age at   Height   Age at    Age at surgery
  age    onset of  (cm)  onset of 
       knee pain    hip pain
III:2   95  M   5   170   60   93 (THR)
III:6   93   F   4   174   55   65, 76 (THR); 
            19, 85 (knees)
III:9   86   F   6   160   60   77 (THR); 
            32, 44 (knees)
IV:1   67   F   7   159  –   50 (elbows)
IV:2   65   F   7   161   –  43 (knees)
IV:5   71   M   2   183   –    – 
IV:9   60  M   4   172   –   –
IV:10   59   M   4   170   –   –
IV:14   52   F   4   161   30   36, 42 (knees)
V:3   42   F   5   178  –   –
V:5   31   F   3   153   –   –
V:6   22   F   3   157  –   –
THR: total hip replacement.
Figure 2. Subject IV:10. Left knee at age 12. The figure shows typical findings with irregular ossi-
fication of the epiphyses and delayed ossification of the patella. 714  Acta Orthopaedica 2009; 80 (6): 711–715
Discussion
Our study of a 6-generation MED family is unique in that 
the affected family members were followed clinically from 
infancy to old age—the oldest up to the age of 95. Our find-
ings show that MED caused by this particular COL9A2 muta-
tion generally starts in early childhood with knee pain, which 
is accompanied by delayed ossification of femoral epiphyses. 
The disease then either stabilizes during puberty, with occa-
sional knee pain, or progresses. Frequently, additional joints 
such as the elbows, hands, and hips then become affected and 
joint surgery may be necessary. Progression of the disease also 
affects muscles, with increasing atrophy, resulting in muscle 
fatigue and pain. 
All of the affected family members in our study were found 
to carry an identical mutation at the donor splice site of exon 
3/intron 3 of the COL9A2 gene, which was dominantly inher-
ited in this 6-generation family. There is a 1 in 2 (or 50%) 
chance that each child of an affected parent will inherit the 
mutation and thus be affected with the disorder. The exons of 
the COL9A2 gene are translated into protein (a subunit of col-
lagen IX), while the introns of the gene are removed and not 
translated. When the mutation is found at the donor splice site, 
it means that it is located right at the site of the cutoff between 
the exon and intron. Muragaki et al. (1996) previously iden-
tified the mutation (IVS3DS [+2] T>C) in one family, and 
concluded that its effect is that exon 3 is not translated at all, 
resulting in a loss of 12 amino acids in the protein product. 
Less than 5% of the mutations that are known to cause domi-
nant MED are located in the COL9A2gene; this type of MED 
is defined as EDM2 (Briggs and Chapman 2002, Jakkula et al. 
2005). The EDM2 mutations are all located at different posi-
tions within the donor splice site of intron 3 and result in an 
in-frame deletion of 12 amino acids from the COL3 domain 
of the collagen chain (Holden et al. 1999, Spayde et al. 2000, 
Fiedler et al. 2002, Nakashima et al. 2005,  Takahashi et al. 
2006). The COL3 domain has proven to be essential for the 
binding between collagen IX and MATN3, an extracellular 
matrix protein in cartilage (Fresquet et al. 2007). Together 
with COL9A1 and COL9A3, COL9A2 forms the collagen IX 
heterotrimer. Previous studies suggest that collagen IX func-
tions as a bridge between collagen fibrils and matrix macro-
molecules in the joint cartilage (Olsen 1997).
In addition to the genetic heterogeneity in MED, there is a 
marked intrafamilial variability in the clinical phenotype, sug-
gesting that environmental and/or modifying genetic factors 
also play a role (Chapman et al. 2003). Despite intrafamilial 
differences in severity of the phenotype, all reported cases of 
EDM2 in addition to our cases have shared the features of 
more severe involvement of the knees and relative sparing of 
the hips (Barrie et al.1958, van Mourik et al. 1998, Holden et 
al. 1999, Fiedler et al. 2002). A few cases with rare additional 
symptoms, such as double-layered patellae (Nakashima et al. 
2005) and ulnar club hands (Takahashi et al. 2006), have been 
reported. Muscular atrophy, which was common in our family, 
has not been reported earlier in cases of EDM2. Muscular atro-
phy has been reported in families with mutated COMP and 
COL9A3 genes (Bönnemann at al. 2000, Jakkula et al. 2003).
In a patient with MED, it is important to carry out a DNA-
based analysis to identify a possible disease-causing mutation. 
This information can be used in genetic risk assessment of 
other family members and to achieve an early and correct diag-
nosis in children in the family with suspected MED. The risk 
for each child of being an affected person is 1 in 2, whereas the 
risk for the offspring of an unaffected person is insignificant. 
There is as yet no curative treatment for the disease, but much 
can be done to alleviate the symptoms, counteract deformi-
ties, and compensate for functional limitations. Families that 
Figure 3. Subject IV:2. Left knee at age 15. The 
femoral epiphyses are flattened, especially the 
medial one.
Figure 4. Subject III:6. Left knee at age 40. The femoral condyles are flattened 
and there is obvious osteoarthritis. A separate bone fragment dorsal to the 
patella is seen in the lateral view.Acta Orthopaedica 2009; 80 (6): 711–715  715
have children with MED need to be in early contact with a 
pediatric  orthopedic  surgeon;  operations  may  be  necessary 
to minimize joint deformation and to preserve mobility. The 
families should also be connected to a center for pediatric 
and youth rehabilitation at an early stage. The occupational 
therapist can work out techniques to help the child to manage 
everyday activities at school and at home. The physiothera-
pist is responsible for evaluation, treatment, and programs for 
motor training. The various therapeutic components should be 
co-ordinated to achieve the best possible results. Adults with 
MED need to continue to interact with an orthopedic surgeon, 
an occupational therapist, and a physiotherapist, and some-
times with a rehabilitation center for adults. Joint replacement 
may become unavoidable with age. 
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